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ABSTRACT Rat brain tubulin possesses two distinct bind-
ing sites for vinblastine per molecule: a high-affinity site with
an affinity constant of 6.2 X 106 M-1 and a low-affinity site with
an affinity constant of 8 X 10 M-1. The high-affinity site is la-
bile, with a tI/2370 of 3.5 hr, is protected by colchicine, and is
unaffected by salt, whereas the ow-affinity site is stable but is
inhibited by salt. Binding to both sites is rapid.
The high-affinity binding constant of vinblastine to tubulin
(6.2 X 10M-1) corresponds to the half-maximal concentration
of vinblastine need to prevent polymerization of tubulin in
vitro, whereas the low-affinity binding constant (8 X 104 M-1)
corresponds to the half-maximal concentration of vinblastine
required to aggregate tubulin. We conclude that vinblastine
binding to the high- and low-affinity sites, respectively, accounts
for the depolymerization and aggregation behavior of tubulin.
Antimitotic agents such as colchicine, podophyllotoxin, and
vinblastine are thought to exert their antimitotic effect, as well
as a number of other intracellular actions (1-4), by virtue of
their ability to prevent tubulin polymerization to microtubules.
For colchicine (5-7) and podophyllotoxin (8, *), affinity con-
stants of these drugs for tubulin are commensurate with the
concentrations required to produce the biological effects.
However, published affinity constants of vinblastine for tubulin
have ranged from 2 X 104 to 8 X 106 M-', and the number of
binding sites for vinblastine/molecule of tubulin (molecular
weight 110,000) has been stated to vary from 0.5 to 2.0 (6,9-12).
Vinblastine has a second effect on tubulin that is not shared
by colchicine or podophyllotoxin, and which is observable both
in vitro and in vivo. This second effect consists of a gradual
aggregation of tubulin monomers from 6 S to 30 S and eventual
precipitation (9, 13). In vivo, this aggregation is recognized as
the reversible formation of macrotubules (340-420 A diameter
instead of 240 A for normal microtubules), which are possibly
formed by the tight coiling of loose helices; these, in turn, are
believed to coalesce to form the paracrystalline arrays seen in
the cytoplasm of many cells treated with vinblastine (14-16).
That these paracrystals are, in fact, composed of tubulin is
suggested by the findings that: they bind colchicine (17); they
bind fluorescent antitubulin antibodies (18); they can be made
in vitro from purified tubulin (15, 19); and, when isolated from
tissues, paracrystals show an amino acid composition identical
to that of purified tubulin (19).
These structural changes occur at higher vinblastine con-
centrations than those required to disaggregate microtubules
and suggested to us that the confusing results on vinblastine
binding affinity and stoichiometry might be resolved if one
postulated two vinblastine binding sites on tubulin: one, high
affinity, whose occupancy is related to microtubule disaggre-
gation and a second site, of lower affinity, related to aggregation
and paracrystal formation. In the present study we provide
evidence that this is indeed the case.
MATERIALS AND METHODS
For polymerization experiments, tubulin was purified from rat
brain extracts by three cycles of polymerization and depoly-
merization, according to the method of Shelanski et al. (20). In
some experiments we used the column procedure of Weisen-
berg et al. (21) or a procedure that combined both of the
methods. After one cycle of polymerization of rat brain tubulin,
the protein was depolymerized in buffer A (10mM Mg9l2, 0.1
mM GTP, and 10mM sodium phosphate, pH 6.8) at 00 for 30
min, applied to a DEAE-cellulose column, and eluted in the
usual fashion. This protein yielded a single band in overloaded
gels by polyacrylamide gel electrophoresis in sodium dodecyl
sulfate (22).
The kinetics of tubule assembly have been studied by tur-
bidimetric measurements at 400 nm as described by Gaskin et
al. (23) in a temperature-controlled chamber of a Cary spec-
trophotometer (model 14) at 37'. The polymerization buffer
contained 0.1 M 2-(N-morpholino)ethanesulfonic acid (Mes)
buffer (pH 6.4), 1 mM ethylene glycol-bis(A-aminoethyl
ether)-N,N'-tetraacetic acid (EGTA), 1 mM GTP, and 0.5mM
MgCl2.
Colchicine binding was determined by the DEAE-filter
paper method (21) or by fluorescence (5).
Vinblastine Binding Assay. The DEAE-filter paper
disc assay for colchicine had to be modified to make it suitable
for vinblastine binding. Two DE-81 paper discs (Whatman)
were washed with cold buffer A (40) by mild suction, taking
care not to dry the paper. The sample (100 ,l) was applied and
was absorbed to filters over a period of 1-2 min. The filters were
then rinsed four times with 4 ml of cold (40) buffer A by mild
suction. The radioactivity of the filter papers was determined
in 10 ml of Hydromix (Yorktown). In all cases, controls were
run in the absence of tubulin, and this blank was subtracted
from the quantity of vinblastine bound in the presence of tu-
bulin. Binding results of duplicate experiments agreed to within
10%. The concentration of protein was determined by the
method of Lowry et al. (24), with crystalline bovine albumin
as a standard.
GTP (Grade II-S) was obtained from Sigma. Podophyllotoxin
was generously supplied by Dr. W. J. Gensler of Boston Uni-
versity. Tritiated colchicine (ring C, [3H]methoxy), a product
of New England Nuclear Corp., had specific activity of 18.45
Ci/mmol. [3H]vinblastine was prepared as described (25), and
had a specific activity about 19 Ci/mmol and about 95% ra-
diochemical purity. Vinblastine sulfate was a gift of Eli Lilly
Laboratories.
Abbreviation: Buffer A, 10mM MgCI2, 0.1 mM GTP, and 10mM so-
dium phosphate (pH 6.8).
* F. Cortese, B. Bhattacharyya, and J. Wolff, submitted for publication.J
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FIG. 1. Scatchard plot of vinblastine binding to rat brain tubulin.
Binding of [3H]vinblastine to tubulin was assayed by the DEAE-filter
disc method as described inMaterials and Methods. Incubations were
at 370 for 30 min. (A) The reaction mixture contained freshly prepared
tubulin (0.2 uM) with increasing concentrations of vinblastine in
buffer A containing 0.25 M sucrose (pH 6.8). (B) The aged tubulin
solution used in this experiment was devoid of colchicine-binding
activity. The incubation mixture contained 0.28.uM tubulin solution
in bufferA containing 0.25M sucrose, with increasing concentrations
of [3H]vinblastine starting from 0.1 X 10-7 M to 1 X 10-4 M. Free
vinblastine concentrations were determined from the difference be-
tween the total and bound ligand.
RESULTS AND DISCUSSION
Affinity constants and binding sites
Preliminary experiments had shown that the binding of vin-
blastine to tubulin was relatively fast, and in the range of con-
centrations used (1 X 10-7 to 5 X 10-5 M vinblastine and 1 X
10-6M tubulin), at 370 less than 15 min were needed to reach
equilibrium. In addition, binding was not strongly temperature
dependent at 0.5MuM (7), and the number of moles of vinblastine
bound per mole of tubulin were 1.35, 1.38, 1.44, and 1.48 at 40,
100, 250, and 370, respectively, when 4.8 X 10-5M vinblastine
was used. Samples were generally incubated for 30 min at 370
and then analyzed. The affinity of vinblastine for freshly pu-
rified rat brain tubulin was determined by analyzing binding
values obtained over a wide range of vinblastine concentration
by the method of Scatchard, as shown in Fig. 1A. In contrast
to previous reports (6, 10, 11), this analysis yielded a nonlinear
Scatchard plot with a concavity upward. This suggested the
presence of two or more classes of binding sites with different
affinities for vinblastine, and results were analyzed on the as-
sumption of two noninteracting sites. Such treatment of the data
yielded a high-affinity site with an association constant, KA, of
6.2 X 106 M-1; 0.74 mole of vinblastine was bound to this site
per mole of tubulin dimer (molecular weight 110,000). This
value for the affinity constant is in agreement with that reported
by Owellen et al. (6, 12). Their report of 0.5 mole of vinblastine
per mole of tubulin can likely be ascribed to decay of this site
with aging (see below) and losses on their filter paper assay.
Also present in tubulin was a second and lower affinity site,
which binds vinblastine with an association constant of 8 X 104
M-1 and a stoichiometry of 1.84 moles of total vinblastine
bound per mole of tubulin. Thus each site approaches a stoi-
chiometry of about 1:1. The second constant appears to be
similar to that reported by Lee et al. (10) (2 X 104 M-1; n = 2)
and to the half-maximal concentration required to produce
fluorescence enhancement of 1-anilino-8-naphthalene sulfonate
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FIG. 2. Effect of preincubation at 370 of rat brain tubulin on
vinbiastine binding. Tubulin was incubated at 37° for the indicated
period and divided into two parts. One part was assayed with 1.2 X
10-7 M [3H]vinblastine for the high-affinity site, and the other part
was assayed with 8 X i0-6 M [3Hjvinblastine for the low-affinity
binding site. In both cases the vinbiastine-binding activity was
measured for 30 min at 370 at the end of the preincubation period.
Conditions for preincubation and binding are: curve 4, low-affinity
site in buffer A; curve 3, high-affinity site in buffer A containing 1 x
10-3 M coichicine; curve 2, high-affinity site in buffer A containing
1 M sucrose; and curve 1, high-affinity site in buffer A. Since the
binding assy with 8 x 10-5M vinbiastine includes both the high- and
low-affinity sites, the value for the low-affinity site was corrected for
the contribution of high-affinity site.
reported earlier (26). Wilson et al. (11) reported an affinity
constant of 2 x 1O5 M-1 for vinbiastine binding to chick brain
tubulin and a stoichiometry of 2 moles of vinblastine per mole
of tubulin. The difference in the low-affinity constants reported
is not currently understood, but may be due, in part, to the
failure to take into account the presence of the high-affinity site.
Stability of the binding sites
Additional differences between these two binding sites for
vinblastine could be readily demonstrated. It is well known (25,
27, *) that colchicine binding to tubulin is labile, and that at 370
the colchicine-binding activity of uncomplexed tubulin decays
in a first-order manner with a t1,,2 of 3-5 hr. Vinblastine and
sucrose protect this binding activity. We were surprised to find,
therefore, that the high-affinity vinbiastine site is equally labile
despite the fact that it is independent of the colchicine-binding
site (6, 27, 28). The protein was pre-incubated at 370 and tested
for its high-affinity site with 1.2 x 10-7 M vinblastine and for
the lower affinity site with 8 x 10-5 M vinblastine. As shown
in the Fig. 2, the high-affinity binding site decayed in a first-
order manner with a ti,2 of 3.5 hr. In contrast, the lower affinity
site did not decay significantly under these incubation condi-
tions (Fig. 2). When tubulin preparations were used that had
been stored at 40 until they were entirely devoid of colchi-
cine-binding activity, we found that there was no vinblastine
binding to the high-affinity site, whereas the low-affinity vim-
blastine site persisted with only slightly impaired affinity (4 x
104 M-1) and a stoichiometry of 0.85 mole of vinbiastine bound
per mole of tubulin (Fig. iB). The posibility that there are twoo
low-affinity binding sites per mole of tubulin, occupancy of
which blocks binding by the high-affinity binding site, would
seem to be discounted by the use of aged tubulin.
Of considerable interest was the observation that just as
vinblastine protects the colchicine-binding site against decay
at 370 (27), so does colchicine protect the high-affinity vim-
blastine-binding site~(Fig. 2). Thus, while there appears to be
no direct interaction between these ligands at their respective
binding sites, site occupation by one ligand protects the other
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FIG. 3. Effects of antimitotic drugs on tubulin polymerization and aggregation. (Left panel) Aliquots of tubulin (1.8 mg/ml) in polymerization
buffer were mixed with different concentrations of vinblastine, colchicine, and podophyllotoxin immediately before incubation at 37°. The
polymerization was monitored by optical density at 400 nm in a temperature-controlled recording spectrophotometer. Data are expressed as
the maximal plateau level reached without drug as 100%. (Right panel) Tubulin (0.8 mg/ml) in polymerization buffer containing 1 ,M vinblastine
was titrated with increasing concentrations of vinblastine. After each addition of vinblastine, the solution was incubated for 15 min at 370, after
which the optical density was measured at 400 nm. Similar titrations were carried out with actin (1.2 mg/ml) and bovine serum albumin (2.4
mg/ml).
site from denaturation. Sucrose (1.0 M) also preserves vinblas-
tine binding of the high-affinity site (Fig. 2).
The addition of denaturing agents such as 1% sodium dodecyl
sulfate or 8 M urea completely abolished vinblastine binding
at both sites in tubulin, indicating the need for the native con-
formation of tubulin for vinblastine binding.
Ionic strength
Since vinblastine is a cation and since it has been reported that
cations strongly influenced the vinblastine-induced aggregation
of tubulin (13), effects of ionic strength on vinblastine binding
to tubulin was investigated. As shown in Table 1, 0.4 M NaCl,
KCI, or NaNO3 had no effect on the binding of vinblastine to
the high-affinity site of tubulin. On the other hand, binding of
vinblastine to the low-affinity site was decreased by about 40%
by each of these salts.t This suggests, on the one hand, that these
salt concentrations do not have a major disruptive effect on the
protein, and on the other, that vinblastine binding to the low-
affinity site has an ionic component.
Correlation of binding to aggregation
In order to test the relation of vinblastine binding to the state
of aggregation of tubulin, the effects of this alkaloid on poly-
merization were studied. As shown by Gaskin et al. (23), tur-
bidity is a reliable measure of microtubule assembly that is in-
dependent of the mass of the monomer and of the length of the
polymer provided this is a rigid rod of a length equal to or
greater than the wavelength of the light used (Appendix of ref.
23). To avoid absorption from colchicine, the wavelength for
measuring light scattering was increased to 400 nm. Optical
density data from a typical polymerization experiment, ex-
pressed as percent of the polymerization obtained in the absence
of drug versus the logarithm of the concentration of vinblastine,
are shown in Fig. 3 (left panel). In this experiment, tubulin
solutions were mixed with different concentrations of.the drug
immediately before incubation and were then incubated in a
temperature-controlled chamber of the spectrophotometer at
370. The half-maximal concentration of vinblastine needed to
prevent polymerization in this experiment was 1.8 X 10-7 M,
which is very similar to the value reported from experiments
in vio (29) for 50% inhibition of mitosis in EBH cells and is
almost identical to the reciprocal of high-affinity constant (6.2
X 106 M-1).
Similar experiments were done with colchicine and podo-
phyllotoxin. The half-maximal concentrations for inhibition
of polymerization are 2.4 X 10-7 M for colchicine and 8.0 X
10-7M for podophyllotoxin. For both of these compounds, these
half-maximal inhibitory concentrations are in good agreement
with their corresponding affinity constants for tubulin, i.e., 3.2
X 106 M-' and 1.8 X 106 M-', respectively (5, 6, *).
As the concentrations of vinblastine were increased there was
a gradual rise in the optical density at 400 nm, which appeared
to approach a plateau at about 4 X 10-4 M vinblastine. As can
be seen in Fig. 3 (right panel), the half-maximal concentration
of vinblastine for aggregation was 2.5 X 10-5 M. This value is
similar to the value calculated for 50% occupancy of the low-
affinity binding site from the second affinity constant (8 x 104
M-1). It is clear, therefore, that the midpoints of both of these
titration curves of Fig. 3 correspond closely to the high- and
low-affinity binding sites of tubulin described above. Further
increases in vinblastine concentrations led to precipitation of
tubulin (at >1 X 10-3 M) and rapid changes in. the optical
density. This appears to be a quite nonspecific effect, in contrast
to the two phenomena mentioned above, since it is shared by
other proteins having acidic isoelectric points, such as serum
albumin or rabbit muscle G actin. Unlike tubulin, these two
proteins do not appear to progress through a clear-cut stage of
oligomer formation.
Table 1. Ionic strength effect on the vinblastine-binding
to tubulin
Inhibition of binding of the
control (%)
Salt High-affinity Low-affinity
(400 mM) site site
NaCl 0 38
KCl 0 37
NaNO3 0 40
Tubulin (1.1 gM) was incubated in buffer A with [3H]vinblas-
tine with and without salts for 30 minutes at 37°. Vinblastine con-
centrations were 1.2 x 10-7 M for the measurement of binding at
the high-affinity site and 8 x 10-5M for the low-affinity site.
t This effect was concentration-dependent over the range tested.
Higher concentration could not be used because of difficulties with
assays that use DEAE-filter paper binding of tubulin.
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Table 2. Comparison of high- and low-affinity vinblastine
binding sites to tubulin
High affinity Low affinity
Affinity constant (6.2 x 106 M-l) (8 X 104 M-1)
Stoichiometry -1. 0 -1. 0
tV2370for decay 3.5 hr (protected >25 hr
by colchicine)
Salt (400 mM) No effect -40% inhibition
Denaturing agents Binding abolished Binding abolished
Effect on state Inhibition of poly- Aggregation (half-
of tubulin merization (half- maximal concen-
maximal concen- tration = 2.4 X
tration = 1.8 x 10-5 M)
10-7 M)
CONCLUSIONS
The dual action of vinblastine on the state of aggregation of
tubulin can be ascribed to the presence on that protein of two
distinct and different binding sites for the alkaloid. The high-
affinity site (KA about 6 X 106 M-1) binds vinblastine at con-
centrations where antimitotic effects and the disappearance
of cytoplasmic microtubules are observed in vivo. A lower af-
finity site (KA about 8 X 104 M-1) is associated with various
aggregation phenomena both in vitro and in vivO (9, 13, 19).
A comparison of the properties of these two sites is given in
Table 2. Both sites are specific, and vinblastine effects at these
concentrations were not observed with the other acidic proteins
examined. On the other hand, the precipitation occurring at
>10-3 M vinblastine is observed with a variety of proteins.
Occupancy of the lower affinity site appears to overcome the
blocking of polymerization caused by occupancy of the high-
affinity site, without apparently interfering with binding to this
site.
Although colchicine and vinblastine do not compete with
each other for their respective binding sites, some sort of
"long-range" or allosteric interaction between the colchicine
and vinblastine sites must occur since occupancy of one site
protects the other. Whether the conformational changes in
tubulin upon colchicine binding (30) have effects on vinblastine
binding, and whether vinblastine will have similar conforma-
tional effects remains to be seen.
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